Advertisement

Topics

PubMed Journals Articles About "There Other Places Form Biotech Companies Than Boston" RSS

03:11 EDT 17th October 2018 | BioPortfolio

There Other Places Form Biotech Companies Than Boston PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest There Other Places Form Biotech Companies Than Boston articles that have been published worldwide.

More Information about "There Other Places Form Biotech Companies Than Boston" on BioPortfolio

We have published hundreds of There Other Places Form Biotech Companies Than Boston news stories on BioPortfolio along with dozens of There Other Places Form Biotech Companies Than Boston Clinical Trials and PubMed Articles about There Other Places Form Biotech Companies Than Boston for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of There Other Places Form Biotech Companies Than Boston Companies in our database. You can also find out about relevant There Other Places Form Biotech Companies Than Boston Drugs and Medications on this site too.

Showing "There Other Places Form Biotech Companies than Boston" PubMed Articles 1–25 of 6,300+

Folate Nutrition Status in Mothers of the Boston Birth Cohort, Sample of a US Urban Low-Income Population.

To examine maternal folic acid supplementation and plasma folate concentrations in the Boston Birth Cohort, a predominantly urban, low-income, minority population in Boston, Massachusetts.


Development and Evaluation of the Boston University Osteoarthritis Functional Pain Short Form (BU-OA-FPS).

Pragmatic studies have gained popularity, thus emphasizing the need for patient-reported outcomes (PRO) to be integrated into electronic health records.

People and places shaping food procurement among recipients of Supplemental Nutrition Assistance Program (SNAP).

A key gap in existing food environment research is a more complex understanding of the interplay between physical and social contexts, including the influence of social networks on food habits. This mixed methods research examined the nature of social connections at food procurement places among a sample of 30 people receiving Supplemental Nutrition Assistance Program (SNAP) benefits in an urban setting. Results highlight the significance of social connections as motivators to use food places, the value of ...


Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.

To compare the outcomes of Boston keratoprosthesis type 1 implantation after failed keratoplasty in patients who are blind or sighted in the contralateral eye.

Inducements by Pharmaceutical Companies: The Elephant in the Room.

Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns.

To evaluate the long-term outcomes of Boston type I keratoprosthesis (B-Kpro) in the management of patients with ocular burn injuries.

Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.

The Boston keratoprosthesis (KPro) is the most commonly used artificial cornea. It has been proven to be successful for severe corneal disease not amenable to keratoplasty. We have observed our patients reporting debilitating glare despite attaining good visual acuities. This motivated us to objectively measure light scatter in eyes with a KPro.

The Perfect and Famous Anesthetic Known as Methyl in Boston in 1895.

Extravagant claims were made for proprietary dental anesthetics in Boston, MA, in the late 1800s. For instance, in 1883, Urial K. Mayo introduced an inhaled Vegetable Anaesthetic comprised of nitrous oxide that had been uselessly pretreated with botanical material. This misguided concept may have been inspired by homeopathy, but it was also in line with the earlier false belief of Elton R. Smilie, Charles T. Jackson, and William T.G. Morton that sulfuric ether could volatilize opium at room temperature. In ...

Boston type I Keratoprosthesis: Antibacterial Resistance and Microbiota Evaluation of Soft Contact Lenses.

To evaluate microbiota colonizing soft contact lenses (CL) in eyes with Boston type I keratoprosthesis (BKPro), and determine the prevalence of resistance to fourth-generation fluoroquinolone (FQ).

Anterior segment optical coherence tomography findings in type I Boston keratoprosthesis.

To report the results of high-resolution anterior segment optical coherence tomography of patients implanted with a type 1 Boston keratoprosthesis (KPro).

Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.

To analyse the anatomical and functionaloutcomes of Boston type II keratoprosthesis at a tertiary eye care centre in South India. Retrospective chart review of 10 patients operated with Boston keratoprosthesis Type 2 between Feb 2013 and June 2017 were analysed. Outcome measures analysed included, visual outcome, device retention and postoperative complications. The most common indication for surgery was SJS in 80% (8 of 10 eyes). Mean follow-up duration was 2.75 years (0.5-5 years, SD - 1.71, median 32...

Optimal Seat Location to Reduce Risk of Thromboembolic Event on Long-Distance Flights: Analysis of 246,766 Seats on the Five Top Airway Companies.

For-Profit Competition From Nonhealthcare Companies: Is Nursing Ready for the Challenge?

The Center for Social Innovation at Boston College.

Established in 2011, the Center for Social Innovation at Boston College has focused on fostering "effective, sustainable social innovations that enhance social justice." the Center is committed to building research evidence that is used for changing practice and works to disseminate findings through a three-channel approach: traditional research publications, convening of practitioners, and through use of media outlets.

Second-quarter biotech job picture.

Research biotech patenting 2017.

Gates unveils biotech-within-a-charity.

Public biotech in 2017-the numbers.

New Nonprofit Biotech From Bill and Melinda Gates.

Improving the practicality and safety of artificial corneas: Pre-assembly and gamma-rays sterilization of the boston keratoprosthesis.

To make the Boston keratoprosthesis (B-KPro), together with its carrier corneal graft, more easily procured, transported and stored, as well as less expensive, easier for the surgeon to implant and safer for the patient, it is proposed that the B-KPro-graft combination be pre-assembled by an expert technician, followed by sterilization with gamma ray irradiation (GI) allowing long-term storage at room temperature. For this to be possible, it must be shown that the B-KPro itself (not only the graft) remains ...

Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.

To report the outcomes of the Boston type I keratoprosthesis (KPro) as the primary penetrating corneal procedure.

Biotech leaders call for free press.

US law threatens flow of foreign capital to biotech sector.

Genetic data sharing: a new type of capital.

Over the last three decades, various biotech companies, mostly in North America, have become experts in the production, processing and analysis of large volumes of genetic data. They have surpassed the performance of traditional academic platforms, by appropriating a new economic model: the two-sided market. Thus, by applying web 2.0 ideas, these biotech companies have made it possible for millions of users to produce and "share" data including genetic data, with each other and with third parties through a...

Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review.

To systematically review the published literature on outcomes of Boston keratoprosthesis type 1 for the treatment of limbal stem cell deficiency secondary to severe chemical corneal injury.


Advertisement
Quick Search
Advertisement
Advertisement